Nerve Recovery Max side effects: every published caution, with the amount beside it

Check 01

Where the cautions on this page come from

No side-effect list was supplied with this stock. Every caution below is quoted from a federal source and carries the amount this panel prints for the ingredient it belongs to.

That last part is the difference this label makes. This panel carries no proprietary blend. No group of ingredients shares one declared weight, so every amount here is the manufacturer’s own printed figure and none had to be derived from a declaration order. So where a caution depends on how much somebody took, a reader here has the figure rather than a maximum. No clinician clause was supplied with this stock, so this site supplies one instead. NIDDK owns this condition and publishes the sentence these pages treat as the most important on them: “For safety reasons, talk with your doctor before using supplements or any complementary or alternative medicines.” ^NIDDK Peripheral neuropathy has causes that need diagnosing, and some are treatable.

Check 02

Vitamin B6: the one ingredient here federal sources connect to causing this condition

One sentence comes first, because a careless page here would do real harm. Nothing on this site says or implies that this bottle will damage anybody’s nerves. The intended 1.7 mg is about one 59th of the Tolerable Upper Intake Level, and the amount printed is a thousandth of that again.

Vitamin B6 is the one ingredient on this panel that federal sources affirmatively connect to causing the kind of problem the product is sold to help with. NIH ODS puts it to consumers in one sentence: “taking high amounts of vitamin B6 from supplements for a year or longer can cause severe nerve damage” ^{NIH ODS}, “leading people to lose control of their bodily movements” ^{NIH ODS}. Its professional fact sheet gives the clinical detail: “chronic administration of 1–6 g oral pyridoxine per day for 12–40 months can cause severe and progressive sensory neuropathy” ^{NIH ODS}.

Read the figures in that second quotation, because they are the scale: grams a day, for a year to more than three years. That is why a Tolerable Upper Intake Level exists, and NIH ODS describes how it was arrived at: “the FNB halved the dose used in these studies to establish a UL of 100 mg/day for adults” ^{NIH ODS}. The adult ceiling is 100 mg a day.

The scale, stated plainly, because the scale is the point

The intended amount on this label is 1.7 mg, inside the ordinary adult intake NIH ODS publishes of 1.3 to 2.0 mg a day and about one 59th of the Upper Intake Level. The amount printed, 1.7 mcg, is one thousandth of that again. Neither figure is anywhere near the doses in the harm literature. Nothing here says or implies that Nerve Recovery Max will damage anybody’s nerves.

The honest point is about a habit rather than a bottle. The reader this protects is the one who adds a second and a third B vitamin product because a label told them their B6 was 100% of something. It takes few bottles to reach 100 mg a day. The label page shows why this label invites the mistake.

Check 03

Alpha lipoic acid, 400 mg, the heaviest thing on the label

The heaviest declared ingredient is also the one with a published side-effect list, and the list is specific enough to be useful.

NCCIH publishes: “The most common side effects of alpha-lipoic acid supplementation are headache, heartburn, nausea, and vomiting.” ^NCCIH Four named effects, all ordinary and digestive rather than serious. The panel prints 400 mg per serving, 12 g across a bottle, against the 600 mg a day used in trials of 6 months to 4 years in people with diabetic polyneuropathy ^{NIH ODS}.

Both halves are quoted because a page printing one without the other would be selling or scaring rather than reporting.

Check 04

The two liver lines, and the qualifier inside one of them

Two of the three botanical lines carry a published liver caution. Both are quoted in full, and the second has a condition this label does not let a reader check.

On ashwagandha, NCCIH: “Although it is rare, there have been a number of cases that link liver injury to ashwagandha supplements.” ^NCCIH The agency quantifies it as rare in the same sentence, which is part of the quotation rather than a softening added here. The panel prints 25 mg per serving, 750 mg across a bottle.

On turmeric, NCCIH: “liver damage has been reported in some people who have consumed these bioavailable formulations.” ^NCCIH Now read the qualifier. These bioavailable formulations points at preparations made to increase absorption. The panel prints Turmeric Powder (Root) at 25 mg, and No extract ratio, marker compound or standardisation percentage is printed for the ashwagandha, the broccoli or the turmeric. So whether what is in this capsule is such a formulation is not published.

Check 05

The rest of the panel, and what nobody has published

That accounts for four of the ten. For the rest there is either nothing published, or something easy to misread.

No caution is published for folate or for benfotiamine at the amounts on this panel. The vitamin B12 row is the one most easily misread on a nerve product: numbness and tingling appear on the NIH ODS page as symptoms of a deficiency, “Neurological changes, such as numbness and tingling in the hands and feet, can also occur” ^{NIH ODS}, which is a different statement from a finding about relief. This site never cites PubMed or PMC as a federal finding: the National Library of Medicine runs that index, and an entry in it is not an agency position.

In one paragraph

The cautions here are the ones federal sources publish about the named ingredients. NIH ODS publishes that high amounts of supplemental vitamin B6 for a year or longer can cause severe nerve damage, and that the adult Upper Intake Level is 100 mg a day; this bottle is about one 59th of that figure, so the risk belongs to stacking rather than to this capsule. NCCIH names four digestive side effects for alpha lipoic acid and liver cautions for ashwagandha and bioavailable turmeric. Because every amount here is printed, each caution can be taken to a clinician with a figure attached.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.